|
|
Article: OTHER NEWS TO NOTE.
- Article from:
- BIOWORLD Today
- Article date:
- December 1, 2003
CopyrightCOPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Agenix Ltd., of Brisbane, Australia, and Biosite Inc., of San Diego, a research-based provider of rapid medical diagnostics, said that Agenix subsidiary, AGEN BioMedical, and Biosite signed a license and supply agreement for D-dimer. Biosite intends to incorporate AGEN's 3B6 antibody, specific for D-dimer, into its Triage Profiler S.O.B. Panel, a potential diagnostic test intended to help physicians identify the cause of shortness of breath, a symptom common to congestive heart failure, heart attack and pulmonary embolism. Financial terms of the agreement were not disclosed.
Amsterdam Molecular Therapeutics BV, of Amsterdam, the Netherlands, reported it ...